Clinical Trials
613 trialsNCT01802346 2026-06-05
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer
University of Southern California
Phase NA Active not recruiting
NCT04322955 2026-06-05
Cyto-KIK
Columbia University
Phase 2 Active not recruiting
NCT06891664 2026-06-05
Feasibility of Day-surgery Management for Patients Undergoing Robotic Radical Prostatectomy: a Randomized Trial
Regina Elena Cancer Institute
Phase NA Active not recruiting
NCT03725761 2026-06-04
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy
University of Wisconsin, Madison
Phase 2 Active not recruiting
NCT04190446 2026-06-04
A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer
Mayo Clinic
Phase 2 Active not recruiting
NCT05751434 2026-06-04
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT03092856 2026-06-03
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
University of Southern California
Phase 2 Active not recruiting
NCT03344211 2026-06-03
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer
University of Southern California
Phase 2 Active not recruiting
NCT04375813 2026-06-03
eRapa
The University of Texas Health Science Center at San Antonio
Phase 2 Active not recruiting
NCT00745355 2026-06-02
Quality of Life in Patients With Bladder Cancer
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT03873805 2026-06-02
PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT05056077 2026-06-02
TTBF
University of California, San Francisco
Phase NA Active not recruiting
NCT05470699 2026-06-02
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer
City of Hope Medical Center
Phase NA Active not recruiting
NCT05477823 2026-06-02
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Active not recruiting
NCT02210117 2026-06-01
Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03012321 2026-06-01
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Northwestern University
Phase 2 Active not recruiting
NCT03600350 2026-06-01
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
University of Wisconsin, Madison
Phase 2 Active not recruiting
NCT04109729 2026-06-01
Rad2Nivo
University of Utah
Phase 1 Active not recruiting
NCT05720910 2026-06-01
FRONE
Institut Bergonié
Phase NA Active not recruiting
NCT06964412 2026-05-29
The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy
Brigham and Women's Hospital
Phase NA Active not recruiting
NCT06523777 2026-05-28
PRISM
Yale University
Active not recruiting
NCT04070209 2026-05-27
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Active not recruiting
NCT04126070 2026-05-27
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT05806814 2026-05-27
OU-SCC-EXCITE
University of Oklahoma
Phase 1 Active not recruiting
NCT07608419 2026-05-27
CZECH-PSMA
General University Hospital, Prague
Active not recruiting
NCT02177292 2026-05-26
SIB
Medical College of Wisconsin
Phase NA Active not recruiting
NCT03582774 2026-05-26
PSMA SRT
Jonsson Comprehensive Cancer Center
Phase 3 Active not recruiting
NCT04263025 2026-05-26
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft
Hackensack Meridian Health
Phase 2/3 Active not recruiting
NCT04731376 2026-05-26
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
Emory University
Phase 1 Active not recruiting
NCT05496959 2026-05-26
LUNAR
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT07607431 2026-05-26
AWARE
Rigshospitalet, Denmark
Active not recruiting
NCT01224288 2026-05-22
Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
NCT03172754 2026-05-22
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
Fox Chase Cancer Center
Phase 1/2 Active not recruiting
NCT03291028 2026-05-22
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Fox Chase Cancer Center
Active not recruiting
NCT04007770 2026-05-22
Acupuncture Pilot Study for Cancer-related Cognitive Function
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05416996 2026-05-22
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT03987386 2026-05-20
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
NCT04388852 2026-05-20
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04879940 2026-05-20
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
NCT05830838 2026-05-20
DAPPER
Mayo Clinic
Phase NA Active not recruiting
NCT06035224 2026-05-19
Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
RenJi Hospital
Phase 2 Active not recruiting
NCT07477626 2026-05-19
RADVAN
Sun Yat-sen University
Phase 3 Active not recruiting
NCT07597369 2026-05-19
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
Peking University First Hospital
Active not recruiting
NCT06904365 2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
NCT00544830 2026-05-15
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06043947 2026-05-15
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Active not recruiting
NCT02312557 2026-05-14
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
OHSU Knight Cancer Institute
Phase 2 Active not recruiting
NCT03574571 2026-05-14
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Active not recruiting
NCT04769817 2026-05-14
ProsTIC Registry of Men Treated With PSMA Theranostics
Peter MacCallum Cancer Centre, Australia
Active not recruiting
NCT07586332 2026-05-14
INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA
Trakya University
Active not recruiting